Particle.news
Download on the App Store

Bhattacharya Poised to Lead CDC as Acting Director After Year of RFK Jr. Upheaval

An expected move to install Jay Bhattacharya as acting CDC director caps a year of leadership turmoil with curtailed vaccine policy.

Overview

  • White House and HHS are expected to name Jay Bhattacharya acting CDC director, with reports indicating he would retain his NIH role simultaneously.
  • CDC leadership has churned since Susan Monarez was fired, an interim successor was later ousted, routine data have been delayed, and health alerts have sharply declined.
  • After replacing the CDC’s vaccine advisory panel, federal guidance dropped universal recommendations for seven childhood shots, despite Kennedy’s pledges to keep the schedule intact.
  • HHS pulled back $11 billion in covid-era grants before a federal judge ordered distribution, while NIH grant cancellations and partial court-ordered reversals left roughly $1.4 billion lost and new awards down about 24% in 2025.
  • Analyses report nearly 2,400 Ph.D. departures across health agencies and widespread vacancies, as states form coalitions like the West Coast Health Alliance to issue evidence-based guidance, with critics linking policy shifts to a growing measles outbreak.